Last reviewed · How we verify
Corticosteroids Triamcinolone Acetonide
At a glance
| Generic name | Corticosteroids Triamcinolone Acetonide |
|---|---|
| Sponsor | Şeyhmus KAPLAN |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Norwegian Trial Comparing Treatment Strategies for Carpal Tunnel Syndrome (PHASE4)
- Evolution of Post-Stroke Shoulder Pain With a Capsular Pattern With Physiotherapy Alone Versus Coupled With Mild Arthrographic Distension With Cortisone (PHASE4)
- Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants (PHASE2)
- Corticosteroid Meniscectomy Randomized Trial (PHASE4)
- Microneedling for Burn Hypertrophic Scars (NA)
- A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) (PHASE2)
- Knee Injections for Obese Patients With Knee Arthritis (PHASE4)
- The Additive Effect of Exercise in Addition to Corticosteroid Injection in Plantar Fasciitis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Corticosteroids Triamcinolone Acetonide CI brief — competitive landscape report
- Corticosteroids Triamcinolone Acetonide updates RSS · CI watch RSS
- Şeyhmus KAPLAN portfolio CI